Loading...
Header Logo
Keywords
Last Name
Institution

Kimberly A Yonkers MD

TitleChair and Professor
Endowed TitleKatz Family Chair in Psychiatry
InstitutionUniversity of Massachusetts Medical School
DepartmentPsychiatry
AddressUniversity of Massachusetts Medical School
55 Lake Avenue North
Worcester MA 01655
Phone508-856-6575
vCardDownload vCard
    Other Positions
    InstitutionUMMS - School of Medicine
    DepartmentObstetrics and Gynecology

    InstitutionUMMS - School of Medicine
    DepartmentPsychiatry


    Collapse Biography 
    Collapse education and training
    Amherst College, Amherst, MA, United StatesBAPolitical Science/Women's Stud
    Columbia University College of Physicians and Surgeons, New York, NY, United StatesMD

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Adams ZM, Ginapp CM, Price CR, Qin Y, Madden LM, Yonkers K, Meyer JP. "A good mother": Impact of motherhood identity on women's substance use and engagement in treatment across the lifespan. J Subst Abuse Treat. 2021 May 14; 130:108474. PMID: 34118710.
      View in: PubMed
    2. Forray A, Yonkers KA. The Collision of Mental Health, Substance Use Disorder, and Suicide. Obstet Gynecol. 2021 May 06. PMID: 33957654.
      View in: PubMed
    3. Yonkers KA. Treatment of Psychiatric Conditions in Pregnancy Starts With Planning. Am J Psychiatry. 2021 03 01; 178(3):213-214. PMID: 33641379.
      View in: PubMed
    4. Krystal JH, Alvarado J, Ball SA, Fortunati FG, Hu M, Ivy ME, Kapo J, Olson KD, Rohrbaugh RM, Sinha R, Tebes JK, Vender RJ, Yonkers KA, Mayes LC. Mobilizing an institutional supportive response for healthcare workers and other staff in the context of COVID-19: The Yale experience. Gen Hosp Psychiatry. 2020 Nov 21; 68:12-18. PMID: 33254081.
      View in: PubMed
    5. Serowik KL, Yonkers KA, Gilstad-Hayden K, Forray A, Zimbrean P, Martino S. Substance Use Disorder Detection Rates Among Providers of General Medical Inpatients. J Gen Intern Med. 2020 Oct 27. PMID: 33111239.
      View in: PubMed
    6. Olmstead TA, Martino S, Ondersma SJ, Gilstad-Hayden K, Forray A, Yonkers KA. The short-term impact on economic outcomes of SBIRT interventions implemented in reproductive health care settings. J Subst Abuse Treat. 2021 Jan; 120:108179. PMID: 33298305.
      View in: PubMed
    7. Lundsberg LS, Cutler AS, Stanwood NL, Yonkers KA, Gariepy AM. Association of Pregnancy Contexts with Depression and Low Social Support in Early Pregnancy. Perspect Sex Reprod Health. 2020 Sep; 52(3):161-170. PMID: 33047499.
      View in: PubMed
    8. Olmstead TA, Yonkers KA, Forray A, Zimbrean P, Gilstad-Hayden K, Martino S. Cost and cost-effectiveness of three strategies for implementing motivational interviewing for substance misuse on medical inpatient units. Drug Alcohol Depend. 2020 Sep 01; 214:108156. PMID: 32659637.
      View in: PubMed
    9. Wong AH, Ray JM, Auerbach MA, Venkatesh AK, McVaney C, Burness D, Chmura C, Saxa T, Sevilla M, Flood CT, Patel A, Whitfill T, Dziura JD, Yonkers KA, Ulrich A, Bernstein SL. Study protocol for the ACT response pilot intervention: development, implementation and evaluation of a systems-based Agitation Code Team (ACT) in the emergency department. BMJ Open. 2020 06 30; 10(6):e036982. PMID: 32606062.
      View in: PubMed
    10. Joudrey PJ, Oldfield BJ, Yonkers KA, O'Connor PG, Berland G, Edelman EJ. Inpatient adoption of medications for alcohol use disorder: A mixed-methods formative evaluation involving key stakeholders. Drug Alcohol Depend. 2020 Jun 02; 213:108090. PMID: 32559667.
      View in: PubMed
    11. Wong AH, Roppolo LP, Chang BP, Yonkers KA, Wilson MP, Powsner S, Rozel JS. Management of Agitation During the COVID-19 Pandemic. West J Emerg Med. 2020 May 22; 21(4):795-800. PMID: 32726244.
      View in: PubMed
    12. Kamody RC, Yonkers K, Pluhar EI, Olezeski CL. Disordered Eating Among Trans-Masculine Youth: Considerations Through a Developmental Lens. LGBT Health. 2020 May/Jun; 7(4):170-173. PMID: 32380892.
      View in: PubMed
    13. Jones RD, Miller J, Vitous CA, Krenz C, Brady KT, Brown AJ, Daumit GL, Drake AF, Fraser VJ, Hartmann KE, Hochman JS, Girdler S, Kalet AL, Libby AM, Mangurian C, Regensteiner JG, Yonkers K, Jagsi R. From Stigma to Validation: A Qualitative Assessment of a Novel National Program to Improve Retention of Physician-Scientists with Caregiving Responsibilities. J Womens Health (Larchmt). 2020 Apr 15. PMID: 32286931.
      View in: PubMed
    14. Yonkers KA, Dailey JI, Gilstad-Hayden K, Ondersma SJ, Forray A, Olmstead TA, Martino S. Abstinence outcomes among women in reproductive health centers administered clinician or electronic brief interventions. J Subst Abuse Treat. 2020 06; 113:107995. PMID: 32359666.
      View in: PubMed
    15. Wisner KL, Yonkers KA. Are Adverse Reproductive Outcomes Associated With the Illness or Its Treatment (or Both)? JAMA Psychiatry. 2019 Dec 01; 76(12):1317-1318. PMID: 31461130.
      View in: PubMed
    16. Jones RD, Miller J, Vitous CA, Krenz C, Brady KT, Brown AJ, Daumit GL, Drake AF, Fraser VJ, Hartmann KE, Hochman JS, Girdler S, Libby AM, Mangurian C, Regensteiner JG, Yonkers K, Jagsi R. The Most Valuable Resource Is Time: Insights From a Novel National Program to Improve Retention of Physician-Scientists With Caregiving Responsibilities. Acad Med. 2019 11; 94(11):1746-1756. PMID: 31348060.
      View in: PubMed
    17. Chang G, Ondersma SJ, Blake-Lamb T, Gilstad-Hayden K, Orav EJ, Yonkers KA. Identification of substance use disorders among pregnant women: A comparison of screeners. Drug Alcohol Depend. 2019 12 01; 205:107651. PMID: 31683243.
      View in: PubMed
    18. Levis B, McMillan D, Sun Y, He C, Rice DB, Krishnan A, Wu Y, Azar M, Sanchez TA, Chiovitti MJ, Bhandari PM, Neupane D, Saadat N, Riehm KE, Imran M, Boruff JT, Cuijpers P, Gilbody S, Ioannidis JPA, Kloda LA, Patten SB, Shrier I, Ziegelstein RC, Comeau L, Mitchell ND, Tonelli M, Vigod SN, Aceti F, Alvarado R, Alvarado-Esquivel C, Bakare MO, Barnes J, Beck CT, Bindt C, Boyce PM, Bunevicius A, Couto TCE, Chaudron LH, Correa H, de Figueiredo FP, Eapen V, Fernandes M, Figueiredo B, Fisher JRW, Garcia-Esteve L, Giardinelli L, Helle N, Howard LM, Khalifa DS, Kohlhoff J, Kusminskas L, Kozinszky Z, Lelli L, Leonardou AA, Lewis BA, Maes M, Meuti V, Nakic Radoš S, Navarro García P, Nishi D, Okitundu Luwa E-Andjafono D, Robertson-Blackmore E, Rochat TJ, Rowe HJ, Siu BWM, Skalkidou A, Stein A, Stewart RC, Su KP, Sundström-Poromaa I, Tadinac M, Tandon SD, Tendais I, Thiagayson P, Töreki A, Torres-Giménez A, Tran TD, Trevillion K, Turner K, Vega-Dienstmaier JM, Wynter K, Yonkers KA, Benedetti A, Thombs BD. Comparison of major depression diagnostic classification probability using the SCID, CIDI, and MINI diagnostic interviews among women in pregnancy or postpartum: An individual participant data meta-analysis. Int J Methods Psychiatr Res. 2019 12; 28(4):e1803. PMID: 31568624.
      View in: PubMed
    19. Martino S, Zimbrean P, Forray A, Kaufman JS, Desan PH, Olmstead TA, Gilstad-Hayden K, Gueorguieva R, Yonkers KA. Implementing Motivational Interviewing for Substance Misuse on Medical Inpatient Units: a Randomized Controlled Trial. J Gen Intern Med. 2019 11; 34(11):2520-2529. PMID: 31468342.
      View in: PubMed
    20. Olmstead TA, Yonkers KA, Ondersma SJ, Forray A, Gilstad-Hayden K, Martino S. Cost-effectiveness of electronic- and clinician-delivered screening, brief intervention and referral to treatment for women in reproductive health centers. Addiction. 2019 09; 114(9):1659-1669. PMID: 31111591.
      View in: PubMed
    21. Ondersma SJ, Chang G, Blake-Lamb T, Gilstad-Hayden K, Orav J, Beatty JR, Goyert GL, Yonkers KA. Accuracy of five self-report screening instruments for substance use in pregnancy. Addiction. 2019 09; 114(9):1683-1693. PMID: 31216102.
      View in: PubMed
    22. Forray A, Martino S, Gilstad-Hayden K, Kershaw T, Ondersma S, Olmstead T, Yonkers KA. Assessment of an electronic and clinician-delivered brief intervention on cigarette, alcohol and illicit drug use among women in a reproductive healthcare clinic. Addict Behav. 2019 09; 96:156-163. PMID: 31100713.
      View in: PubMed
    23. Ecker J, Abuhamad A, Hill W, Bailit J, Bateman BT, Berghella V, Blake-Lamb T, Guille C, Landau R, Minkoff H, Prabhu M, Rosenthal E, Terplan M, Wright TE, Yonkers KA. Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic: a report of a joint workshop of the Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists, and American Society of Addiction Medicine. Am J Obstet Gynecol. 2019 07; 221(1):B5-B28. PMID: 30928567.
      View in: PubMed
    24. Thibaut F, Chagraoui A, Buckley L, Gressier F, Labad J, Lamy S, Potenza MN, Rondon M, Riecher-Rössler A, Soyka M, Yonkers K. WFSBP * and IAWMH ** Guidelines for the treatment of alcohol use disorders in pregnant women. World J Biol Psychiatry. 2019 01; 20(1):17-50. PMID: 30632868.
      View in: PubMed
    25. Loree AM, Yonkers KA, Ondersma SJ, Gilstad-Hayden K, Martino S. Comparing satisfaction, alliance and intervention components in electronically delivered and in-person brief interventions for substance use among childbearing-aged women. J Subst Abuse Treat. 2019 04; 99:1-7. PMID: 30797381.
      View in: PubMed
    26. Lundsberg LS, Peglow S, Qasba N, Yonkers KA, Gariepy AM. Is Preconception Substance Use Associated With Unplanned or Poorly Timed Pregnancy? J Addict Med. 2018 Jul/Aug; 12(4):321-328. PMID: 29570477.
      View in: PubMed
    27. Yonkers KA, Simoni M. Evidence-Based Treatments for Premenstrual Disorders. Am J Obstet Gynecol. 2018 08; 219(2):215-216. PMID: 29673568.
      View in: PubMed
    28. Jagsi R, Jones RD, Griffith KA, Brady KT, Brown AJ, Davis RD, Drake AF, Ford D, Fraser VJ, Hartmann KE, Hochman JS, Girdler S, Libby AM, Mangurian C, Regensteiner JG, Yonkers K, Escobar-Alvarez S, Myers ER. An Innovative Program to Support Gender Equity and Success in Academic Medicine: Early Experiences From the Doris Duke Charitable Foundation's Fund to Retain Clinical Scientists. Ann Intern Med. 2018 07 17; 169(2):128-130. PMID: 29554690.
      View in: PubMed
    29. Martino S, Ondersma SJ, Forray A, Olmstead TA, Gilstad-Hayden K, Howell HB, Kershaw T, Yonkers KA. A randomized controlled trial of screening and brief interventions for substance misuse in reproductive health. Am J Obstet Gynecol. 2018 03; 218(3):322.e1-322.e12. PMID: 29247636.
      View in: PubMed
    30. Yonkers KA, Gilstad-Hayden K, Forray A, Lipkind HS. Association of Panic Disorder, Generalized Anxiety Disorder, and Benzodiazepine Treatment During Pregnancy With Risk of Adverse Birth Outcomes. JAMA Psychiatry. 2017 11 01; 74(11):1145-1152. PMID: 28903165.
      View in: PubMed
    31. Yonkers KA. Polyunsaturated Fatty Acids, Highly Unsaturated Fatty Acids, and Perinatal Depression. Biol Psychiatry. 2017 10 15; 82(8):542-543. PMID: 28935095.
      View in: PubMed
    32. Loree AM, Gariepy A, Ruger JP, Yonkers KA. Postpartum Contraceptive use and Rapid Repeat Pregnancy Among Women who use Substances. Subst Use Misuse. 2018 01 02; 53(1):162-169. PMID: 28937912.
      View in: PubMed
    33. Forray A, Gilstad-Hayden K, Suppies C, Bogen D, Sofuoglu M, Yonkers KA. Progesterone for smoking relapse prevention following delivery: A pilot, randomized, double-blind study. Psychoneuroendocrinology. 2017 Dec; 86:96-103. PMID: 28926762.
      View in: PubMed
    34. Yonkers KA, Forray A, Smith MV. Maternal Antidepressant Use and Pregnancy Outcomes. JAMA. 2017 08 15; 318(7):665-666. PMID: 28810017.
      View in: PubMed
    35. Yonkers KA, Simoni MK. Premenstrual disorders. Am J Obstet Gynecol. 2018 01; 218(1):68-74. PMID: 28571724.
      View in: PubMed
    36. Ondersma SJ, Martino S, Svikis DS, Yonkers KA. Commentary on Kim et al. (2017): Staying focused on non-treatment seekers. Addiction. 2017 05; 112(5):828-829. PMID: 28378329.
      View in: PubMed
    37. Ko JY, Wolicki S, Barfield WD, Patrick SW, Broussard CS, Yonkers KA, Naimon R, Iskander J. CDC Grand Rounds: Public Health Strategies to Prevent Neonatal Abstinence Syndrome. MMWR Morb Mortal Wkly Rep. 2017 Mar 10; 66(9):242-245. PMID: 28278146.
      View in: PubMed
    38. Xu X, Yonkers KA, Ruger JP. Economic evaluation of a behavioral intervention versus brief advice for substance use treatment in pregnant women: results from a randomized controlled trial. BMC Pregnancy Childbirth. 2017 03 07; 17(1):83. PMID: 28270105.
      View in: PubMed
    39. Gariepy A, Lundsberg LS, Vilardo N, Stanwood N, Yonkers K, Schwarz EB. Pregnancy context and women's health-related quality of life. Contraception. 2017 May; 95(5):491-499. PMID: 28188745.
      View in: PubMed
    40. Yonkers KA, Cameron B, Gueorguieva R, Altemus M, Kornstein SG. The Influence of Cyclic Hormonal Contraception on Expression of Premenstrual Syndrome. J Womens Health (Larchmt). 2017 Apr; 26(4):321-328. PMID: 27854559.
      View in: PubMed
    41. Wright TE, Terplan M, Ondersma SJ, Boyce C, Yonkers K, Chang G, Creanga AA. The role of screening, brief intervention, and referral to treatment in the perinatal period. Am J Obstet Gynecol. 2016 Nov; 215(5):539-547. PMID: 27373599.
      View in: PubMed
    42. Gariepy AM, Lundsberg LS, Miller D, Stanwood NL, Yonkers KA. Are pregnancy planning and pregnancy timing associated with maternal psychiatric illness, psychological distress and support during pregnancy? J Affect Disord. 2016 Nov 15; 205:87-94. PMID: 27423065.
      View in: PubMed
    43. Smith MV, Gotman N, Yonkers KA. Early Childhood Adversity and Pregnancy Outcomes. Matern Child Health J. 2016 Apr; 20(4):790-8. PMID: 26762511.
      View in: PubMed
    44. Yonkers KA, Kornstein SG, Gueorguieva R, Merry B, Van Steenburgh K, Altemus M. Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2015 Oct; 72(10):1037-44. PMID: 26351969.
      View in: PubMed
    45. Martino S, Zimbrean P, Forray A, Kaufman J, Desan P, Olmstead TA, Gueorguieva R, Howell H, McCaherty A, Yonkers KA. See One, Do One, Order One: a study protocol for cluster randomized controlled trial testing three strategies for implementing motivational interviewing on medical inpatient units. Implement Sci. 2015 Sep 29; 10:138. PMID: 26420671.
      View in: PubMed
    46. Gariepy AM, Lundsberg LS, Stolar M, Stanwood NL, Yonkers KA. Are pregnancy planning and timing associated with preterm or small for gestational age births? Fertil Steril. 2015 Dec; 104(6):1484-92. PMID: 26364840.
      View in: PubMed
    47. Coughlin CG, Blackwell KA, Bartley C, Hay M, Yonkers KA, Bloch MH. Obstetric and neonatal outcomes after antipsychotic medication exposure in pregnancy. Obstet Gynecol. 2015 May; 125(5):1224-35. PMID: 25932852.
      View in: PubMed
    48. Forray A, Merry B, Lin H, Ruger JP, Yonkers KA. Perinatal substance use: a prospective evaluation of abstinence and relapse. Drug Alcohol Depend. 2015 May 01; 150:147-55. PMID: 25772437.
      View in: PubMed
    49. Smith MV, Costello D, Yonkers KA. Clinical correlates of prescription opioid analgesic use in pregnancy. Matern Child Health J. 2015 Mar; 19(3):548-56. PMID: 24951127.
      View in: PubMed
    50. Yonkers KA, Forray A, Nich C, Carroll KM, Hine C, Merry BC, Shaw H, Shaw J, Sofuoglu M. Progesterone Reduces Cocaine Use in Postpartum Women with a Cocaine Use Disorder: A Randomized,Double-Blind Study. Lancet Psychiatry. 2014 Oct 01; 1(5):360-367. PMID: 25328863.
      View in: PubMed
    51. Yonkers KA, Smith MV, Forray A, Epperson CN, Costello D, Lin H, Belanger K. Pregnant women with posttraumatic stress disorder and risk of preterm birth. JAMA Psychiatry. 2014 Aug; 71(8):897-904. PMID: 24920287.
      View in: PubMed
    52. Xu X, Yonkers KA, Ruger JP. Costs of a motivational enhancement therapy coupled with cognitive behavioral therapy versus brief advice for pregnant substance users. PLoS One. 2014; 9(4):e95264. PMID: 24760017.
      View in: PubMed
    53. Cole-Lewis HJ, Kershaw TS, Earnshaw VA, Yonkers KA, Lin H, Ickovics JR. Pregnancy-specific stress, preterm birth, and gestational age among high-risk young women. Health Psychol. 2014 Sep; 33(9):1033-45. PMID: 24447189.
      View in: PubMed
    54. Hartlage SA, Breaux CA, Yonkers KA. Addressing concerns about the inclusion of premenstrual dysphoric disorder in DSM-5. J Clin Psychiatry. 2014 Jan; 75(1):70-6. PMID: 24345853.
      View in: PubMed
    55. Forray A, Gotman N, Kershaw T, Yonkers KA. Perinatal smoking and depression in women with concurrent substance use. Addict Behav. 2014 Apr; 39(4):749-56. PMID: 24447885.
      View in: PubMed
    56. Yonkers KA, Blackwell KA, Glover J, Forray A. Antidepressant use in pregnant and postpartum women. Annu Rev Clin Psychol. 2014; 10:369-92. PMID: 24313569.
      View in: PubMed
    57. Rakofsky JJ, Schettler PJ, Kinkead BL, Frank E, Judd LL, Kupfer DJ, Rush AJ, Thase ME, Yonkers KA, Rapaport MH. The prevalence and severity of depressive symptoms along the spectrum of unipolar depressive disorders: a post hoc analysis. J Clin Psychiatry. 2013 Nov; 74(11):1084-91. PMID: 24330894.
      View in: PubMed
    58. Huang H, Coleman S, Bridge JA, Yonkers K, Katon W. A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight. Gen Hosp Psychiatry. 2014 Jan-Feb; 36(1):13-8. PMID: 24094568.
      View in: PubMed
    59. Yonkers KA, Pearlstein TB, Gotman N. A pilot study to compare fluoxetine, calcium, and placebo in the treatment of premenstrual syndrome. J Clin Psychopharmacol. 2013 Oct; 33(5):614-20. PMID: 23963058.
      View in: PubMed
    60. Garlow SJ, Kinkead B, Thase ME, Judd LL, Rush AJ, Yonkers KA, Kupfer DJ, Frank E, Schettler PJ, Rapaport MH. Fluoxetine increases suicide ideation less than placebo during treatment of adults with minor depressive disorder. J Psychiatr Res. 2013 Sep; 47(9):1199-203. PMID: 23786912.
      View in: PubMed
    61. Nevatte T, O'Brien PM, Bäckström T, Brown C, Dennerstein L, Endicott J, Epperson CN, Eriksson E, Freeman EW, Halbreich U, Ismail K, Panay N, Pearlstein T, Rapkin A, Reid R, Rubinow D, Schmidt P, Steiner M, Studd J, Sundström-Poromaa I, Yonkers K. ISPMD consensus on the management of premenstrual disorders. Arch Womens Ment Health. 2013 Aug; 16(4):279-91. PMID: 23624686.
      View in: PubMed
    62. Yonkers KA. The possible effects of depressive symptoms on risk of preterm birth are clouded by lack of control over confounding factors. Evid Based Med. 2013 Oct; 18(5):194-5. PMID: 23328968.
      View in: PubMed
    63. Smith MV, Sung A, Shah B, Mayes L, Klein DS, Yonkers KA. Neurobehavioral assessment of infants born at term and in utero exposure to serotonin reuptake inhibitors. Early Hum Dev. 2013 Feb; 89(2):81-6. PMID: 22999988.
      View in: PubMed
    64. Yonkers KA, Norwitz ER, Smith MV, Lockwood CJ, Gotman N, Luchansky E, Lin H, Belanger K. Depression and serotonin reuptake inhibitor treatment as risk factors for preterm birth. Epidemiology. 2012 Sep; 23(5):677-85. PMID: 22627901.
      View in: PubMed
    65. Yonkers KA, Forray A, Howell HB, Gotman N, Kershaw T, Rounsaville BJ, Carroll KM. Motivational enhancement therapy coupled with cognitive behavioral therapy versus brief advice: a randomized trial for treatment of hazardous substance use in pregnancy and after delivery. Gen Hosp Psychiatry. 2012 Sep-Oct; 34(5):439-49. PMID: 22795046.
      View in: PubMed
    66. Quesada O, Gotman N, Howell HB, Funai EF, Rounsaville BJ, Yonkers KA. Prenatal hazardous substance use and adverse birth outcomes. J Matern Fetal Neonatal Med. 2012 Aug; 25(8):1222-7. PMID: 22489543.
      View in: PubMed
    67. Epperson CN, Steiner M, Hartlage SA, Eriksson E, Schmidt PJ, Jones I, Yonkers KA. Premenstrual dysphoric disorder: evidence for a new category for DSM-5. Am J Psychiatry. 2012 May; 169(5):465-75. PMID: 22764360.
      View in: PubMed
    68. Hartlage SA, Freels S, Gotman N, Yonkers K. Criteria for premenstrual dysphoric disorder: secondary analyses of relevant data sets. Arch Gen Psychiatry. 2012 Mar; 69(3):300-5. PMID: 22393222.
      View in: PubMed
    69. Davis KJ, Yonkers KA. Making lemonade out of lemons: a case report and literature review of external pressure as an intervention with pregnant and parenting substance-using women. J Clin Psychiatry. 2012 Jan; 73(1):51-6. PMID: 22316576.
      View in: PubMed
    70. Yonkers KA, Gotman N, Smith MV, Forray A, Belanger K, Brunetto WL, Lin H, Burkman RT, Zelop CM, Lockwood CJ. Does antidepressant use attenuate the risk of a major depressive episode in pregnancy? Epidemiology. 2011 Nov; 22(6):848-54. PMID: 21900825.
      View in: PubMed
    71. Yonkers KA, Howell HB, Gotman N, Rounsaville BJ. Self-report of illicit substance use versus urine toxicology results from at-risk pregnant women. J Subst Use. 2011 Oct 01; 16(5):372-389. PMID: 23956685.
      View in: PubMed
    72. Yonkers KA, Vigod S, Ross LE. Diagnosis, pathophysiology, and management of mood disorders in pregnant and postpartum women. Obstet Gynecol. 2011 Apr; 117(4):961-77. PMID: 21422871.
      View in: PubMed
    73. Smith MV, Shao L, Howell H, Lin H, Yonkers KA. Perinatal depression and birth outcomes in a Healthy Start project. Matern Child Health J. 2011 Apr; 15(3):401-9. PMID: 20300813.
      View in: PubMed
    74. Buist A, Gotman N, Yonkers KA. Generalized anxiety disorder: course and risk factors in pregnancy. J Affect Disord. 2011 Jun; 131(1-3):277-83. PMID: 21269708.
      View in: PubMed
    75. Leibenluft E, Yonkers KA. The ties that bind: maternal-infant interactions and the neural circuitry of postpartum depression. Am J Psychiatry. 2010 Nov; 167(11):1294-6. PMID: 21041250.
      View in: PubMed
    76. Yonkers KA, Gotman N, Kershaw T, Forray A, Howell HB, Rounsaville BJ. Screening for prenatal substance use: development of the Substance Use Risk Profile-Pregnancy scale. Obstet Gynecol. 2010 Oct; 116(4):827-33. PMID: 20859145.
      View in: PubMed
    77. Smith MV, Gotman N, Lin H, Yonkers KA. Do the PHQ-8 and the PHQ-2 accurately screen for depressive disorders in a sample of pregnant women? Gen Hosp Psychiatry. 2010 Sep-Oct; 32(5):544-8. PMID: 20851275.
      View in: PubMed
    78. Yonkers KA, Wisner KL, Stewart DE, Oberlander TF, Dell DL, Stotland N, Ramin S, Chaudron L, Lockwood C. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Gen Hosp Psychiatry. 2009 Sep-Oct; 31(5):403-13. PMID: 19703633.
      View in: PubMed
    79. Yonkers KA, Smith MV, Gotman N, Belanger K. Typical somatic symptoms of pregnancy and their impact on a diagnosis of major depressive disorder. Gen Hosp Psychiatry. 2009 Jul-Aug; 31(4):327-33. PMID: 19555792.
      View in: PubMed
    80. Yonkers KA, Howell HB, Allen AE, Ball SA, Pantalon MV, Rounsaville BJ. A treatment for substance abusing pregnant women. Arch Womens Ment Health. 2009 Aug; 12(4):221-7. PMID: 19350369.
      View in: PubMed
    81. Lancaster GI, O'Connell R, Katz DL, Manson JE, Hutchison WR, Landau C, Yonkers KA. The expanding medical and behavioral resources with access to care for everyone health plan. Ann Intern Med. 2009 Apr 07; 150(7):490-2. PMID: 19258548.
      View in: PubMed
    82. Yonkers KA, Smith MV, Lin H, Howell HB, Shao L, Rosenheck RA. Depression screening of perinatal women: an evaluation of the healthy start depression initiative. Psychiatr Serv. 2009 Mar; 60(3):322-8. PMID: 19252044.
      View in: PubMed
    83. Yonkers KA. Parsing risk for the use of selective serotonin reuptake inhibitors in pregnancy. Am J Psychiatry. 2009 Mar; 166(3):268-70. PMID: 19255046.
      View in: PubMed
    84. Cunningham J, Yonkers KA, O'Brien S, Eriksson E. Update on research and treatment of premenstrual dysphoric disorder. Harv Rev Psychiatry. 2009; 17(2):120-37. PMID: 19373620.
      View in: PubMed
    85. Smith MV, Shao L, Howell H, Wang H, Poschman K, Yonkers KA. Success of mental health referral among pregnant and postpartum women with psychiatric distress. Gen Hosp Psychiatry. 2009 Mar-Apr; 31(2):155-62. PMID: 19269536.
      View in: PubMed
    86. Spoozak L, Gotman N, Smith MV, Belanger K, Yonkers KA. Evaluation of a social support measure that may indicate risk of depression during pregnancy. J Affect Disord. 2009 Apr; 114(1-3):216-23. PMID: 18765164.
      View in: PubMed
    87. Yonkers KA, O'Brien PM, Eriksson E. Premenstrual syndrome. Lancet. 2008 Apr 05; 371(9619):1200-10. PMID: 18395582.
      View in: PubMed
    88. Wallenstein GV, Blaisdell-Gross B, Gajria K, Guo A, Hagan M, Kornstein SG, Yonkers KA. Development and validation of the Premenstrual Symptoms Impact Survey (PMSIS): a disease-specific quality of life assessment tool. J Womens Health (Larchmt). 2008 Apr; 17(3):439-50. PMID: 18328013.
      View in: PubMed
    89. Yonkers KA, Lin H, Howell HB, Heath AC, Cohen LS. Pharmacologic treatment of postpartum women with new-onset major depressive disorder: a randomized controlled trial with paroxetine. J Clin Psychiatry. 2008 Apr; 69(4):659-65. PMID: 18363420.
      View in: PubMed
    90. Hine CE, Howell HB, Yonkers KA. Integration of medical and psychological treatment within the primary health care setting. Soc Work Health Care. 2008; 47(2):122-34. PMID: 18956504.
      View in: PubMed
    91. Bernstein IH, Rush AJ, Yonkers K, Carmody TJ, Woo A, McConnell K, Trivedi MH. Symptom features of postpartum depression: are they distinct? Depress Anxiety. 2008; 25(1):20-6. PMID: 17187349.
      View in: PubMed
    92. Kessler RC, Gruber M, Hettema JM, Hwang I, Sampson N, Yonkers KA. Co-morbid major depression and generalized anxiety disorders in the National Comorbidity Survey follow-up. Psychol Med. 2008 Mar; 38(3):365-74. PMID: 18047766.
      View in: PubMed
    93. Borenstein JE, Dean BB, Leifke E, Korner P, Yonkers KA. Differences in symptom scores and health outcomes in premenstrual syndrome. J Womens Health (Larchmt). 2007 Oct; 16(8):1139-44. PMID: 17937566.
      View in: PubMed
    94. Yonkers KA. The treatment of women suffering from depression who are either pregnant or breastfeeding. Am J Psychiatry. 2007 Oct; 164(10):1457-9. PMID: 17898329.
      View in: PubMed
    95. Borenstein JE, Dean BB, Yonkers KA, Endicott J. Using the daily record of severity of problems as a screening instrument for premenstrual syndrome. Obstet Gynecol. 2007 May; 109(5):1068-75. PMID: 17470584.
      View in: PubMed
    96. Halbreich U, Backstrom T, Eriksson E, O'brien S, Calil H, Ceskova E, Dennerstein L, Douki S, Freeman E, Genazzani A, Heuser I, Kadri N, Rapkin A, Steiner M, Wittchen HU, Yonkers K. Clinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studies. Gynecol Endocrinol. 2007 Mar; 23(3):123-30. PMID: 17454164.
      View in: PubMed
    97. Rogal SS, Poschman K, Belanger K, Howell HB, Smith MV, Medina J, Yonkers KA. Effects of posttraumatic stress disorder on pregnancy outcomes. J Affect Disord. 2007 Sep; 102(1-3):137-43. PMID: 17291588.
      View in: PubMed
    98. Dean BB, Borenstein JE, Knight K, Yonkers K. Evaluating the criteria used for identification of PMS. J Womens Health (Larchmt). 2006 Jun; 15(5):546-55. PMID: 16796482.
      View in: PubMed
    99. Smith MV, Poschman K, Cavaleri MA, Howell HB, Yonkers KA. Symptoms of posttraumatic stress disorder in a community sample of low-income pregnant women. Am J Psychiatry. 2006 May; 163(5):881-4. PMID: 16648330.
      View in: PubMed
    100. Yonkers KA, Holthausen GA, Poschman K, Howell HB. Symptom-onset treatment for women with premenstrual dysphoric disorder. J Clin Psychopharmacol. 2006 Apr; 26(2):198-202. PMID: 16633152.
      View in: PubMed
    101. Steiner M, Pearlstein T, Cohen LS, Endicott J, Kornstein SG, Roberts C, Roberts DL, Yonkers K. Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs. J Womens Health (Larchmt). 2006 Jan-Feb; 15(1):57-69. PMID: 16417420.
      View in: PubMed
    102. Halbreich U, O'Brien PM, Eriksson E, Bäckström T, Yonkers KA, Freeman EW. Are there differential symptom profiles that improve in response to different pharmacological treatments of premenstrual syndrome/premenstrual dysphoric disorder? CNS Drugs. 2006; 20(7):523-47. PMID: 16800714.
      View in: PubMed
    103. Pearlstein TB, Bachmann GA, Zacur HA, Yonkers KA. Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation. Contraception. 2005 Dec; 72(6):414-21. PMID: 16307962.
      View in: PubMed
    104. Yonkers KA, Brown C, Pearlstein TB, Foegh M, Sampson-Landers C, Rapkin A. Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder. Obstet Gynecol. 2005 Sep; 106(3):492-501. PMID: 16135578.
      View in: PubMed
    105. Bruce SE, Yonkers KA, Otto MW, Eisen JL, Weisberg RB, Pagano M, Shea MT, Keller MB. Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry. 2005 Jun; 162(6):1179-87. PMID: 15930067.
      View in: PubMed
    106. Pearlstein T, Yonkers KA, Fayyad R, Gillespie JA. Pretreatment pattern of symptom expression in premenstrual dysphoric disorder. J Affect Disord. 2005 Apr; 85(3):275-82. PMID: 15780697.
      View in: PubMed
    107. Yonkers KA, Pearlstein T, Fayyad R, Gillespie JA. Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase. J Affect Disord. 2005 Apr; 85(3):317-21. PMID: 15780701.
      View in: PubMed
    108. Perkonigg A, Yonkers KA, Pfister H, Lieb R, Wittchen HU. Risk factors for premenstrual dysphoric disorder in a community sample of young women: the role of traumatic events and posttraumatic stress disorder. J Clin Psychiatry. 2004 Oct; 65(10):1314-22. PMID: 15491233.
      View in: PubMed
    109. Judd LL, Rapaport MH, Yonkers KA, Rush AJ, Frank E, Thase ME, Kupfer DJ, Plewes JM, Schettler PJ, Tollefson G. Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder. Am J Psychiatry. 2004 Oct; 161(10):1864-71. PMID: 15465984.
      View in: PubMed
    110. Cohen LS, Soares CN, Yonkers KA, Bellew KM, Bridges IM, Steiner M. Paroxetine controlled release for premenstrual dysphoric disorder: a double-blind, placebo-controlled trial. Psychosom Med. 2004 Sep-Oct; 66(5):707-13. PMID: 15385695.
      View in: PubMed
    111. Yonkers KA. Management strategies for PMS/PMDD. J Fam Pract. 2004 Sep; Suppl:S15-20. PMID: 15508358.
      View in: PubMed
    112. Brawman-Mintzer O, Yonkers KA. New trends in the treatment of anxiety disorders. CNS Spectr. 2004 Aug; 9(8 Suppl 7):19-27. PMID: 15303077.
      View in: PubMed
    113. Yonkers KA, Wisner KL, Stowe Z, Leibenluft E, Cohen L, Miller L, Manber R, Viguera A, Suppes T, Altshuler L. Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry. 2004 Apr; 161(4):608-20. PMID: 15056503.
      View in: PubMed
    114. Smith MV, Rosenheck RA, Cavaleri MA, Howell HB, Poschman K, Yonkers KA. Screening for and detection of depression, panic disorder, and PTSD in public-sector obstetric clinics. Psychiatr Serv. 2004 Apr; 55(4):407-14. PMID: 15067153.
      View in: PubMed
    115. Yonkers KA, Pearlstein T, Rosenheck RA. Premenstrual disorders: bridging research and clinical reality. Arch Womens Ment Health. 2003 Nov; 6(4):287-92. PMID: 14628181.
      View in: PubMed
    116. Borenstein JE, Dean BB, Endicott J, Wong J, Brown C, Dickerson V, Yonkers KA. Health and economic impact of the premenstrual syndrome. J Reprod Med. 2003 Jul; 48(7):515-24. PMID: 12953326.
      View in: PubMed
    117. Yonkers KA. Paroxetine treatment of mood disorders in women: premenstrual dysphoric disorder and hot flashes. Psychopharmacol Bull. 2003; 37 Suppl 1:135-47. PMID: 14566208.
      View in: PubMed
    118. Yonkers KA, Bruce SE, Dyck IR, Keller MB. Chronicity, relapse, and illness--course of panic disorder, social phobia, and generalized anxiety disorder: findings in men and women from 8 years of follow-up. Depress Anxiety. 2003; 17(3):173-9. PMID: 12768651.
      View in: PubMed
    119. Yonkers KA. Special issues related to the treatment of depression in women. J Clin Psychiatry. 2003; 64 Suppl 18:8-13. PMID: 14700449.
      View in: PubMed
    120. Halbreich U, Bergeron R, Yonkers KA, Freeman E, Stout AL, Cohen L. Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder. Obstet Gynecol. 2002 Dec; 100(6):1219-29. PMID: 12468166.
      View in: PubMed
    121. Le Bon O, Yonkers K, Armitage R. More sleep cycles in the mid-luteal phase of a healthy control. Acta Neurol Belg. 2002 Dec; 102(4):186-7. PMID: 12534246.
      View in: PubMed
    122. Pearlstein T, Yonkers KA. Review of fluoxetine and its clinical applications in premenstrual dysphoric disorder. Expert Opin Pharmacother. 2002 Jul; 3(7):979-91. PMID: 12083997.
      View in: PubMed
    123. Yonkers KA, Brawman-Mintzer O. The pharmacologic treatment of depression: is gender a critical factor? J Clin Psychiatry. 2002 Jul; 63(7):610-5. PMID: 12143920.
      View in: PubMed
    124. Yonkers K. Review: progesterone or progesterone lead to a marginal reduction in premenstrual syndrome symptoms. Evid Based Ment Health. 2002 May; 5(2):56. PMID: 12026905.
      View in: PubMed
    125. Rapaport MH, Judd LL, Schettler PJ, Yonkers KA, Thase ME, Kupfer DJ, Frank E, Plewes JM, Tollefson GD, Rush AJ. A descriptive analysis of minor depression. Am J Psychiatry. 2002 Apr; 159(4):637-43. PMID: 11925303.
      View in: PubMed
    126. Yonkers KA, Ramin SM, Rush AJ, Navarrete CA, Carmody T, March D, Heartwell SF, Leveno KJ. Onset and persistence of postpartum depression in an inner-city maternal health clinic system. Am J Psychiatry. 2001 Nov; 158(11):1856-63. PMID: 11691692.
      View in: PubMed
    127. Freeman EW, Rickels K, Yonkers KA, Kunz NR, McPherson M, Upton GV. Venlafaxine in the treatment of premenstrual dysphoric disorder. Obstet Gynecol. 2001 Nov; 98(5 Pt 1):737-44. PMID: 11704162.
      View in: PubMed
    128. Yonkers KA, Dyck IR, Keller MB. An eight-year longitudinal comparison of clinical course and characteristics of social phobia among men and women. Psychiatr Serv. 2001 May; 52(5):637-43. PMID: 11331798.
      View in: PubMed
    129. Howell HB, Brawman-Mintzer O, Monnier J, Yonkers KA. Generalized anxiety disorder in women. Psychiatr Clin North Am. 2001 Mar; 24(1):165-78. PMID: 11225506.
      View in: PubMed
    130. Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, Gelenberg AJ, Ryan CE, Hess AL, Harrison W, Davis SM, Keller MB. Gender differences in chronic major and double depression. J Affect Disord. 2000 Oct; 60(1):1-11. PMID: 10940442.
      View in: PubMed
    131. Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, Gelenberg AJ, Davis SM, Harrison WM, Keller MB. Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry. 2000 Sep; 157(9):1445-52. PMID: 10964861.
      View in: PubMed
    132. Yonkers KA, Dyck IR, Warshaw M, Keller MB. Factors predicting the clinical course of generalised anxiety disorder. Br J Psychiatry. 2000 Jun; 176:544-9. PMID: 10974960.
      View in: PubMed
    133. Pearlstein TB, Halbreich U, Batzar ED, Brown CS, Endicott J, Frank E, Freeman EW, Harrison WM, Haskett RF, Stout AL, Yonkers KA. Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo. J Clin Psychiatry. 2000 Feb; 61(2):101-9. PMID: 10732657.
      View in: PubMed
    134. Leibenluft E, Ashman SB, Feldman-Naim S, Yonkers KA. Lack of relationship between menstrual cycle phase and mood in a sample of women with rapid cycling bipolar disorder. Biol Psychiatry. 1999 Aug 15; 46(4):577-80. PMID: 10459410.
      View in: PubMed
    135. Yonkers KA. Medical management of premenstrual dysphoric disorder. J Gend Specif Med. 1999 May-Jun; 2(3):55-60. PMID: 11252853.
      View in: PubMed
    136. Gurguis GN, Yonkers KA, Phan SP, Blakeley JE, Williams A, Rush AJ. Adrenergic receptors in premenstrual dysphoric disorder: I. Platelet alpha 2 receptors: Gi protein coupling, phase of menstrual cycle, and prediction of luteal phase symptom severity. Biol Psychiatry. 1998 Oct 01; 44(7):600-9. PMID: 9787884.
      View in: PubMed
    137. Rush AJ, Armitage R, Gillin JC, Yonkers KA, Winokur A, Moldofsky H, Vogel GW, Kaplita SB, Fleming JB, Montplaisir J, Erman MK, Albala BJ, McQuade RD. Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder. Biol Psychiatry. 1998 Jul 01; 44(1):3-14. PMID: 9646878.
      View in: PubMed
    138. Gurguis GN, Yonkers KA, Blakeley JE, Phan SP, Williams A, Rush AJ. Adrenergic receptors in premenstrual dysphoric disorder. II. Neutrophil beta2-adrenergic receptors: Gs protein coupling, phase of menstrual cycle and prediction of luteal phase symptom severity. Psychiatry Res. 1998 Jun 02; 79(1):31-42. PMID: 9676824.
      View in: PubMed
    139. Yonkers KA, Zlotnick C, Allsworth J, Warshaw M, Shea T, Keller MB. Is the course of panic disorder the same in women and men? Am J Psychiatry. 1998 May; 155(5):596-602. PMID: 9585708.
      View in: PubMed
    140. Yonkers KA, Little BB, March D. Lithium During Pregnancy : Drug Effects and Their Therapeutic Implications. CNS Drugs. 1998 Apr; 9(4):261-9. PMID: 27521009.
      View in: PubMed
    141. Yonkers KA. Assessing unipolar mood disorders in women. Psychopharmacol Bull. 1998; 34(3):261-6. PMID: 9803751.
      View in: PubMed
    142. Yonkers KA, Halbreich U, Freeman E, Brown C, Endicott J, Frank E, Parry B, Pearlstein T, Severino S, Stout A, Stone A, Harrison W. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group. JAMA. 1997 Sep 24; 278(12):983-8. PMID: 9307345.
      View in: PubMed
    143. Armitage R, Yonkers K, Cole D, Rush AJ. A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients. J Clin Psychopharmacol. 1997 Jun; 17(3):161-8. PMID: 9169959.
      View in: PubMed
    144. Kocsis JH, Zisook S, Davidson J, Shelton R, Yonkers K, Hellerstein DJ, Rosenbaum J, Halbreich U. Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes. Am J Psychiatry. 1997 Mar; 154(3):390-5. PMID: 9054788.
      View in: PubMed
    145. Shelton RC, Davidson J, Yonkers KA, Koran L, Thase ME, Pearlstein T, Halbreich U. The undertreatment of dysthymia. J Clin Psychiatry. 1997 Feb; 58(2):59-65. PMID: 9062374.
      View in: PubMed
    146. Yonkers KA, Clark RH, Trivedi MH. The psychopharmacological treatment of nonmajor mood disorders. Mod Probl Pharmacopsychiatry. 1997; 25:146-66. PMID: 9344374.
      View in: PubMed
    147. Yonkers KA. Antidepressants in the treatment of premenstrual dysphoric disorder. J Clin Psychiatry. 1997; 58 Suppl 14:4-10; discussion 11-3. PMID: 9418742.
      View in: PubMed
    148. Davis L, Yonkers KA. Diagnosis and treatment of premenstrual dysphoric disorder. Int J Psychiatry Clin Pract. 1997; 1(3):149-56. PMID: 24940830.
      View in: PubMed
    149. Yonkers KA. The association between premenstrual dysphoric disorder and other mood disorders. J Clin Psychiatry. 1997; 58 Suppl 15:19-25. PMID: 9427873.
      View in: PubMed
    150. Yonkers KA. Anxiety symptoms and anxiety disorders: how are they related to premenstrual disorders? J Clin Psychiatry. 1997; 58 Suppl 3:62-7; discussion 68-9. PMID: 9133494.
      View in: PubMed
    151. Goldenberg IM, White K, Yonkers K, Reich J, Warshaw MG, Goisman RM, Keller MB. The infrequency of "pure culture" diagnoses among the anxiety disorders. J Clin Psychiatry. 1996 Nov; 57(11):528-33. PMID: 8968302.
      View in: PubMed
    152. Yonkers KA, Ellison JM, Shera DM, Pratt LA, Cole JO, Fierman E, Keller MB, Lavori PW. Description of antipanic therapy in a prospective longitudinal study. J Clin Psychopharmacol. 1996 Jun; 16(3):223-32. PMID: 8784654.
      View in: PubMed
    153. Halbreich U, Petty F, Yonkers K, Kramer GL, Rush AJ, Bibi KW. Low plasma gamma-aminobutyric acid levels during the late luteal phase of women with premenstrual dysphoric disorder. Am J Psychiatry. 1996 May; 153(5):718-20. PMID: 8615423.
      View in: PubMed
    154. Yonkers KA, Warshaw MG, Massion AO, Keller MB. Phenomenology and course of generalised anxiety disorder. Br J Psychiatry. 1996 Mar; 168(3):308-13. PMID: 8833684.
      View in: PubMed
    155. Yonkers KA, Gullion C, Williams A, Novak K, Rush AJ. Paroxetine as a treatment for premenstrual dysphoric disorder. J Clin Psychopharmacol. 1996 Feb; 16(1):3-8. PMID: 8834412.
      View in: PubMed
    156. Yonkers KA, Halbreich U, Freeman E, Brown C, Pearlstein T. Sertraline in the treatment of premenstrual dysphoric disorder. Psychopharmacol Bull. 1996; 32(1):41-6. PMID: 8927673.
      View in: PubMed
    157. Yonkers KA, Chantilis SJ. Recognition of depression in obstetric/gynecology practices. Am J Obstet Gynecol. 1995 Aug; 173(2):632-8. PMID: 7645645.
      View in: PubMed
    158. Kornstein SG, Schatzberg AF, Yonkers KA, Thase ME, Keitner GI, Ryan CE, Schlager D. Gender differences in presentation of chronic major depression. Psychopharmacol Bull. 1995; 31(4):711-8. PMID: 8851644.
      View in: PubMed
    159. Armitage R, Yonkers KA. Case report: menstrual-related very short REM latency in a healthy normal control. Sleep. 1994 Jun; 17(4):345-7. PMID: 7973319.
      View in: PubMed
    160. Keller MB, Yonkers KA, Warshaw MG, Pratt LA, Gollan JK, Massion AO, White K, Swartz AR, Reich J, Lavori PW. Remission and relapse in subjects with panic disorder and panic with agoraphobia: a prospective short-interval naturalistic follow-up. J Nerv Ment Dis. 1994 May; 182(5):290-6. PMID: 10678311.
      View in: PubMed
    161. Rogers MP, White K, Warshaw MG, Yonkers KA, Rodriguez-Villa F, Chang G, Keller MB. Prevalence of medical illness in patients with anxiety disorders. Int J Psychiatry Med. 1994; 24(1):83-96. PMID: 8077085.
      View in: PubMed
    162. Yonkers KA, Harrison W. The inclusion of women in psychopharmacologic trials. J Clin Psychopharmacol. 1993 Dec; 13(6):380-2. PMID: 8120150.
      View in: PubMed
    163. Fierman EJ, Hunt MF, Pratt LA, Warshaw MG, Yonkers KA, Peterson LG, Epstein-Kaye TM, Norton HS. Trauma and posttraumatic stress disorder in subjects with anxiety disorders. Am J Psychiatry. 1993 Dec; 150(12):1872-4. PMID: 8238645.
      View in: PubMed
    164. Warshaw MG, Fierman E, Pratt L, Hunt M, Yonkers KA, Massion AO, Keller MB. Quality of life and dissociation in anxiety disorder patients with histories of trauma or PTSD. Am J Psychiatry. 1993 Oct; 150(10):1512-6. PMID: 8379556.
      View in: PubMed
    165. Severino SK, Yonkers KA. A literature review of psychotic symptoms associated with the premenstruum. Psychosomatics. 1993 Jul-Aug; 34(4):299-306. PMID: 8351304.
      View in: PubMed
    166. Reich J, Warshaw M, Peterson LG, White K, Keller M, Lavori P, Yonkers KA. Comorbidity of panic and major depressive disorder. J Psychiatr Res. 1993; 27 Suppl 1:23-33. PMID: 8145180.
      View in: PubMed
    167. Yonkers KA, White K. Premenstrual exacerbation of depression: one process or two? J Clin Psychiatry. 1992 Aug; 53(8):289-92. PMID: 1500406.
      View in: PubMed
    168. Yonkers KA, Kando JC, Cole JO, Blumenthal S. Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication. Am J Psychiatry. 1992 May; 149(5):587-95. PMID: 1575248.
      View in: PubMed
    169. Yonkers KA, Ellison JM, Shera DM, Pratt LA, Langford LM, Cole JO, White K, Lavori PW, Keller MB. Pharmacotherapy observed in a large prospective longitudinal study on anxiety disorders. Psychopharmacol Bull. 1992; 28(2):131-7. PMID: 1513915.
      View in: PubMed
    For assistance with using Profiles, please refer to the online tutorials or contact UMMS Help Desk or call 508-856-8643.
    Yonkers's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description